Brief: Champions Oncology reports Q1 GAAP loss per share $ 0.26

Champions Oncology

09/09/2016 13:15

Sept 9 (Reuters) - Champions Biotechnology Inc  CSBR.O  
    * Q1 revenue rose 30 percent to $3.7 million 
    * Sees FY 2017 revenue $16 million to $18 million 
    * Beats revenue guidance for quarter; Reaffirms full year 
guidance of 43-60 pct revenue growth 
    * Sees FY revenue up 43 to 60 percent 
    * Says reaffirms full year revenue guidance for FY2017 of 
$16 - $18 million 
    * Qtrly GAAP loss per share $ 0.26 
    * Qtrly non-GAAP loss per share $0.15 
 
Source text for Eikon:  ID:nPndzsq8a  
Further company coverage:  CSBR.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))